No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Therapeutic monoclonal antibodies (mAbs ... In this review, introductory notes on the development and systematic nomenclature of therapeutic mAbs in general, set the stage for a detailed ...

Despite its vital role in "kick-starting" the immune response, IgD is arguably the least understood antibody, with little known about how it might participate in other parts of the immune system. A ...

However, recent advancements in immunotherapy have revolutionized cancer treatment by using the body's own immune system to fight cancer. Monoclonal antibodies (mAbs) and immune checkpoint inhibitors ...

Nevertheless, classification criteria often seem to be arbitrarily chosen, and the nomenclature that is used to describe their features often varies. Consequently, communication among ...

The antibody nomenclature follows the title of the corresponding search entry in the RCSB PDB database, with verification done through the original literature. In cases where the name in the original ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

Karen Miller, the great-great-great-granddaughter of victim Catherine Eddowes, called for the naming of the serial killer in court as a "form of justice" Kirsty Hatcher is an Associate Editor on ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, ...